![Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today](https://ibdnewstoday.com/wp-content/uploads/2016/03/shutterstock_392092564-375x475@2x.jpg)
Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today
![ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry ( ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry (](https://medicalupdateonline.com/wp-content/uploads/2016/05/ECCO-2016-Part-1-ECCO-EFCCA-Pat-Guidelines.jpg)
ECCO 2016: Professor Séverine Vermeire (Leuven, Belgium) discusses new patient guidelines for Crohn's disease and ulcerative colitis which were released at this year's 11th Congress of ECCO in Amsterdam, and Helen Terry (
Biotherapy monitoring, a major area of interest at the European Crohn's and Colitis Organisation (ECCO) Congress
![ECCO 2017: European Cancer Congress - The voice of multidisciplinary cancer care in Europe | HealthManagement.org ECCO 2017: European Cancer Congress - The voice of multidisciplinary cancer care in Europe | HealthManagement.org](https://res.cloudinary.com/healthmanagement-org/image/upload/f_auto,fl_lossy/v1469607607/cw/00108183_cw_image.jpg)